Ep. 2 Dr Stephen Robinson on manufacturing medicines for NTDs
'The color of a tablet seems like a trivial thing, but it is not.'
Tune in to our in-depth conversation with Dr Stephen Robinson, Pharmaceutical Development Director at DNDi.
Stephen oversees all Chemistry, Manufacturing and Control (CMC) work for both DNDi and our sister organization GARDP. In this interview, he talks in particular about zoliflodacin, a newly registered antibiotic for gonorrhea developed by GARDP; about acoziborole, a new single-dose oral treatment for sleeping sickness developed by DNDi; and explains why CMC is a shared resource between GARDP and DNDi.
More information on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.